23andMe’s stock falls after company says there’s substantial doubt it can stay in business
Me Holding Co.’s stock turned down early Tuesday, after the DNA-testing company reported its latest quarterly loss, shedding gains made late Monday after it announced it would cut 40% of its workforce as part of a restructuring.
23andMe to lay off 40% of its workforce as stock price plummets
The genetic testing company 23andMe is cutting 40% of its workforce and ending its therapeutics program as its stock price continues to plummet. CBS News correspondent Carter Evans has more on what this means for its customers.
23andMe announces layoffs totaling 40% of workforce, discontinues therapeutics division
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs.
23andMe reports sales decline day after announcing plans to cut 40% of workforce
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company announced a cost-cutting plan.
23andMe Lays Off 40% of Its Workforce as Company Spirals
The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire workforce, according to a press release Monday. The move is part of a restructuring that will see the company also halt the development of its therapeutics division which had been working on various potential medical treatments.
23andMe announces layoffs, will cut 40% of workforce
The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile data breach.
23andMe is laying off 40% of its workforce right before the holiday season
Me is laying off 40% of its workforce right before the holiday season - The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile data breach,
23andMe customer? What to know about the privacy of your genetic data.
Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.
23andMe is ending its cancer research program and slashing over 200 jobs
23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s ...
Yahoo14h
What 23andMe business troubles could mean for millions of users' genetic data
The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of ...
PCMag on MSN1d
23andMe to Cut 40% of Its Staff Amid Grim Financials
The DNA testing kit company is also discontinuing new developments to its therapeutics program, which has been focused on ...
Benzinga.com1d
Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs
23andMe is actively exploring all strategic options in parallel ... The company reported a loss per share of $2.32 compared ...
23andMe Reports Second Quarter Fiscal Year 2025 Financial Results
SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, ...
NBC Los Angeles2d
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Shares were hovering below $1 until 23andMe announced a 1-for-20 reverse stock split in October. In September, all seven ...
What 23andMe business troubles could mean for users' genetic data
Companies, 23andMe included, also have a responsibility to notify consumers of changes and get "consumers' affirmative ...
Yahoo Finance18h
23andMe to lay off more than 200 employees amid business struggles
23andMe’s layoffs and business restructuring are the latest challenges for the once high-flying firm, which went public in ...